• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • TRUBIND AT WORK
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Presentations
    • Exhibitions

Enabling Data for Challenging Targets

Back-Scattering Interferometry (BSI) provides direct binding Kd determinations with label-free, conformation-sensitive detection, delivering significant advantages versus conventional methods for intractable drug targets in complex matrices.

The team of scientists at Molecular Sensing are working with a growing list of challenging targets as listed below. Over time, our researchers will publish summaries of their work on these targets under the title, “BSI at Work.”  Please follow the links below to learn more about our progress with particular targets of interest.

Integral Membrane Proteins

GPCR’s (Class A,B, C)
Ion channels
Receptor tyrosine kinases
Photoredox complexes

Soluble Protein Targets

Kinases
Transcription factors
Contractile protein complexes
Protein fibrils
Protein-protein interactors

 Allosteric Membrane & Protein Targets

Complex Matrices

Crude membrane fractions
Lysates & tissue extracts
Nanodiscs, lipoparticles
Serum

DRUG DISCOVERY SERVICES

  • ASSAY DEVELOPMENT
  • SECONDARY SCREENING
  • TRUBIND AT WORK
    • PPI INTERACTIONS
    • TARGETING GPCRs
    • KINASE INTERACTIONS

SLAS2015 Exhibition & Tutorial

Visit our booth #1619 and attend our Tuesday Tutorial on Conformation-Sensitive Assay Detection for Accelerated Drug Discovery Research. Learn about the superior analytical power of TruBind™ Back Scattering Interferometry (BSI) technology for molecular interaction studies.
LEARN MORE>
© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy